Hydrocodone is a semi-synthetic opioid analgesic used to relieve moderate to severe pain and is often prescribed in combination with non-opioid medications such as acetaminophen. It was first approved for medical use in the United States in 1943 and has since become one of the most commonly prescribed opioid medications for short-term pain management. Hydrocodone works by binding to opioid receptors in the brain and spinal cord, altering the perception of pain and emotional response to it. While it is effective for pain control, its use is associated with significant risks including drowsiness, nausea, constipation, respiratory depression, tolerance, physical dependence, and potential for misuse and addiction.
BRAND NAMES
Vicodin
Norco
Lortab
Hycet
Zohydro ER
Hysingla ER
MECHANISM OF ACTION
Hydrocodone works by binding to mu-opioid receptors in the brain and spinal cord. This reduces the transmission of pain signals and changes how the brain perceives pain, leading to pain relief along with effects like sedation and euphoria.
PHARMACOKINETICS
Absorption
Hydrocodone is well absorbed from the gastrointestinal tract after oral administration, with peak plasma concentrations typically occurring within about 1–2 hours for immediate-release formulations. Its bioavailability is moderate due to first-pass hepatic metabolism. Food may slightly delay absorption but does not significantly affect overall drug exposure.
Distribution
Hydrocodone is widely distributed in the body and readily crosses the blood–brain barrier to reach the central nervous system, where it produces its analgesic effects. It has moderate plasma protein binding and a relatively large volume of distribution.
Metabolism
Hydrocodone is primarily metabolized in the liver by the cytochrome P450 enzyme system, mainly CYP3A4 (N-demethylation to norhydrocodone) and CYP2D6 (O-demethylation to hydromorphone, an active metabolite). These metabolic pathways contribute to both its analgesic effects and variability in response among individuals due to genetic differences in enzyme activity.
Elimination
Hydrocodone is mainly eliminated through the kidneys in urine as both unchanged drug and metabolites. It has a short half-life of about 3–4 hours, and its clearance may be prolonged in patients with liver or kidney impairment.
PHARMACODYNAMICS
Hydrocodone produces pain relief by activating mu-opioid receptors in the brain and spinal cord, which reduces the transmission and perception of pain signals. It also causes sedation, euphoria, and respiratory depression in a dose-dependent manner.
ADMINISTRATION
Hydrocodone is given orally in immediate-release or extended-release forms, often combined with acetaminophen. The dose depends on pain severity and must be taken exactly as prescribed due to risks of dependence and respiratory depression.
DOSAGE AND STRENGTH
Hydrocodone is available in different strengths (commonly 2.5 mg to 10 mg, often combined with acetaminophen).
The doctor selects the strength based on the patient’s pain level and medical history.
Immediate-release forms are usually taken every 4–6 hours as needed.
Extended-release forms are taken every 12 hours for continuous pain control.
DRUG INTERACTIONS
Hydrocodone should not be combined with CNS depressants like alcohol, benzodiazepines, or sedatives due to risk of severe respiratory depression.
Avoid or monitor use with CYP3A4 inhibitors (e.g., ketoconazole, erythromycin) as they can increase drug levels.
Be cautious with CYP3A4 inducers (e.g., rifampin, carbamazepine) as they can reduce effectiveness.
CYP2D6 inhibitors may reduce formation of the active metabolite and decrease pain relief.
FOOD INTERACTIONS
Hydrocodone has minimal food interactions, though high-fat meals may slightly delay absorption. Alcohol should be avoided because it increases sedation and risk of respiratory depression. Grapefruit products may increase drug levels and side effects.
CONTRAINDICATIONS
Hydrocodone should not be used in patients with severe respiratory depression, acute asthma in unmonitored settings, or gastrointestinal obstruction. It is also contraindicated in those with hypersensitivity to the drug. Caution is needed in severe liver disease due to increased risk of toxicity.
SIDE EFFECTS
Drowsiness
Dizziness
Nausea
Vomiting
Constipation
OVER DOSE
Severe respiratory depression
Extreme drowsiness or coma
Pinpoint pupils (miosis)
Slowed or stopped breathing
Low blood pressure
TOXICITY
Hydrocodone toxicity mainly causes severe respiratory and CNS depression, leading to extreme drowsiness, confusion, coma, and potentially death. It may also cause pinpoint pupils, low blood pressure, and reduced oxygen levels. Long-term or high-dose use increases the risk of dependence and serious harm.
